EN DE
Watch Kim Forest Enterprise Co., Ltd. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Kim Forest Enterprise Co., Ltd. (6645) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Kim Forest Enterprise Co., Ltd. stock TWD 5.35, price TWD 12.75, that is 58.0% below the price, quality 35 out of 100. Rating: strongly overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare TW

KF Kim Forest Enterprise Co., Ltd. logo Thin data Nov 4, 2026

Kim Forest Enterprise Co., Ltd.

6645 · TW
Very expensive, weak quality

Our calculation puts a fair price 58% below what the stock costs today.

Low debt
Revenue last quarter +23% vs. a year ago.
Fair value 5.35 TWD · Strongly overvalued (−58.0%)
Quality 35/100
Weak Growth (revenue 3y −6.4 %/yr in TWD)
Loss-making · -22.6% net margin (TTM)
Negative free cash flow
Trails peers (3/10)
Narrow moat 12/100
Thin data
Watch Kim Forest Enterprise Co., Ltd. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

47.62 TWD 11.70 TWD Fair Value 5.35 TWD May 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.

How to read this chart

60‑month range 11.70 TWD – 47.62 TWD · fair‑value band 4.00 TWD – 7.99 TWD · the 12.75 TWD price screens above the 5.35 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.

Follow Kim Forest Enterprise Co. in your weekly email

Every Wednesday you see whether Kim Forest Enterprise Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States.

Show moreShow less

The company provides genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It offers bioinformatics service items; prenatal test kits; and genetically modified models.

In addition, the company offers SARS-CoV-2 detection kits. Further, it engages in the wholesale of medical instruments and consumables; and provision of various genetic and medical testing services. The company was founded in 2004 and is headquartered in New Taipei City, Taiwan.

Stock analysis

Kim Forest Enterprise Co., Ltd. (6645) currently trades at 12.75 TWD, while our model-based Fair Value estimate is 5.35 TWD, 58% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 93/100, which puts the data coverage at low.

Scenario range: 4.00 TWD (bear) to 7.99 TWD (bull), the price of 12.75 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 35/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Kim Forest Enterprise Co., Ltd. reported revenue of 549M TWD in FY2025 versus 601M TWD in FY2021, a compound −2.2%/yr. Reported net income was −146M TWD in FY2025.

Key figures

Market cap 771M TWD (≈ $23.5M) Micro · P/S ratio 1.29 · EPS (TTM) −2.24 TWD · Net margin −22.6% · Return on equity −28.5% · Return on assets (EBIT) −3.6% (5-year average) · Operating margin −22.4% · Revenue (TTM) 600M TWD.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).

What moves the price

The share trades about 42% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −9% fair-value upside, at −58%, 6645 screens richer than that median.

Fair Value models

Bear 4.00 TWD Fair Value 5.35 TWD Bull 7.99 TWD
Price 12.75 TWD · Downside -58.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) 4.00 TWD 5.35 TWD 7.99 TWD 54
All 1 models by family
Asset-Based
NCAV (Graham) 4.00 TWD 5.35 TWD 7.99 TWD 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 35/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 9
How much profit the company makes from its sales and capital
Quality Growth 73
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 45
Debt, balance sheet and risk of trouble
Investment 74
Does it invest with discipline instead of growing at any price?
Low Volatility 67
How calm the share price moves, does not count
Price momentum 27
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 4
Distance to the 52-week high, does not count
New shares 42
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+9.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.6%
Start year 2020 (pandemic). Over 10 years: +7.4% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−11.0% (2020) → −25.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

6645 screens overvalued: fair value 58% below the price. Compare with Thermo Fisher Scientific Inc →

Compare Kim Forest Enterprise Co., Ltd. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 126 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 35 · Bottom 25%
Fair Value upside −58.0% · Below median
Profitability
Return on assets −14.4% · Bottom 25%
Net margin (12 months) −22.6% · Bottom 25%
Operating margin (12 months) −22.4% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 23.2% · Top 25%
Balance sheet
Debt / equity 0.22× · Above median

Valuation Multiplesvs Diagnostics & Research median · lower = cheaper

P/B 1.57× · Cheaper than median
P/S (12 months) 1.29× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)100 · sector 39
PAST (return on equity)0 · sector 15
HEALTH (low debt)89 · sector 95
DIVIDEND (yield)0 · sector 33

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
WuXi AppTec Co 603259 ¥147.00 ¥164.66 +12% vs 6645
IQVIA Holdings IQV $271.83 $299.01 +10% vs 6645
Illumina, Inc ILMN $213.13 $228.80 +7% vs 6645
Thermo Fisher Scientific Inc TMO $694.76 $686.04 −1% vs 6645
Danaher Corporation DHR $230.25 $209.18 −9% vs 6645
IDEXX Laboratories, Inc IDXX $676.04 $496.48 −27% vs 6645
Mettler-Toledo International Inc MTD $1,722 $650.28 −62% vs 6645
Agilent Technologies, Inc A $174.76 $64.53 −63% vs 6645
Lonza Group LONN CHF 663.40 CHF 153.50 −77% vs 6645
Waters Corporation WAT $457.60 $91.26 −80% vs 6645

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Kim Forest Enterprise Co., Ltd.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Kim Forest Enterprise Co., Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/6645

Frequently asked questions

Is Kim Forest Enterprise Co., Ltd. (6645) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 5.35 TWD versus a price of 12.75 TWD, about 58% lower (overvalued).
What is the fair value of 6645?
Our model-based fair value for Kim Forest Enterprise Co., Ltd. is 5.35 TWD (as of Nov 4, 2026), built from audited fundamentals. The current price: 12.75 TWD.
What is the quality score of 6645?
Kim Forest Enterprise Co., Ltd. has a Quality Score of 35/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kim Forest Enterprise Co., Ltd. (6645)?
Our model-based price target is the fair value of 5.35 TWD (as of Nov 4, 2026) from 1 valuation models. Cautious scenario 4.00 TWD, optimistic scenario 7.99 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Kim Forest Enterprise Co., Ltd. stock forecast for 2026?
Our models put fair value at 5.35 TWD, about 58% lower versus a price of 12.75 TWD (overvalued). Cautious scenario 4.00 TWD, optimistic scenario 7.99 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Kim Forest Enterprise Co., Ltd. (6645)?
Kim Forest Enterprise Co., Ltd. reported trailing-twelve-month revenue of about 600M TWD (latest available figure, as of Nov 4, 2026).
What is the intrinsic value of Kim Forest Enterprise Co., Ltd. (6645)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kim Forest Enterprise Co., Ltd. it is 5.35 TWD per share (as of Nov 4, 2026), against a price of 12.75 TWD. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Kim Forest Enterprise Co., Ltd. stock overvalued or undervalued in 2026?
As of Nov 4, 2026, 6645 trades above its calculated fair value: price 12.75 TWD, fair value 5.35 TWD, a gap of about −58% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6645?
No. The price is what the market pays today (12.75 TWD); the fair value is what the company's own numbers justify (5.35 TWD). For Kim Forest Enterprise Co., Ltd. the two are 7.40 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Kim Forest Enterprise Co., Ltd. worth?
The market values Kim Forest Enterprise Co., Ltd. at about 771M TWD (market capitalisation, as of Nov 4, 2026). Per share that is 12.75 TWD; our models calculate a fair value of 5.35 TWD per share.
What do the bullish and bearish scenarios say about 6645?
Our models span a range for Kim Forest Enterprise Co., Ltd.: cautious scenario 4.00 TWD, base 5.35 TWD, optimistic 7.99 TWD per share (as of Nov 4, 2026, price 12.75 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Kim Forest Enterprise Co., Ltd. (6645)?
Balance-sheet figures for Kim Forest Enterprise Co., Ltd. (as of Nov 4, 2026): return on equity −28.5%, debt of 0.22 per unit of equity. They feed the Quality Score of 35/100, which measures business quality independently of the share price.
How far is 6645 from its 52-week high?
Kim Forest Enterprise Co., Ltd. trades at 12.75 TWD, about 42% below its 52-week high of 22.00 TWD and 9% above the low of 11.70 TWD (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 5.35 TWD is for.
Which stocks are comparable to Kim Forest Enterprise Co., Ltd.?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, Lonza Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kim Forest Enterprise Co., Ltd. stock attractive at the current price?
The data as of Nov 4, 2026: price 12.75 TWD, calculated fair value 5.35 TWD (−58%), Quality Score 35/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6645 calculated?
We run Kim Forest Enterprise Co., Ltd. through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of 5.35 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Kim Forest Enterprise Co., Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kim Forest Enterprise Co., Ltd. (6645)?
The closing price on Nov 6, 2026 was 12.75 TWD. Our model-based fair value is 5.35 TWD, about 58% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kim Forest Enterprise Co., Ltd. right now?
The price sits above even our optimistic bull case (7.99 TWD). The favourable scenario is already priced in. Weak quality (35/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (4.00 TWD to 7.99 TWD) leaves room in how you read the outcome.

Key figures of Kim Forest Enterprise Co., Ltd.

How large is the market capitalisation of Kim Forest Enterprise Co., Ltd. (6645)?
The market capitalisation of Kim Forest Enterprise Co., Ltd. is 771M TWD (≈ $23.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kim Forest Enterprise Co., Ltd. (6645)?
The price-to-sales ratio of Kim Forest Enterprise Co., Ltd. is 1.29 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Kim Forest Enterprise Co., Ltd. (6645)?
Earnings per share at Kim Forest Enterprise Co., Ltd. are −2.24 TWD. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Kim Forest Enterprise Co., Ltd. (6645)?
The net margin of Kim Forest Enterprise Co., Ltd. is −22.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kim Forest Enterprise Co., Ltd. (6645)?
The return on equity (ROE) of Kim Forest Enterprise Co., Ltd. is −28.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kim Forest Enterprise Co., Ltd. (6645)?
On an EBIT basis the return on assets of Kim Forest Enterprise Co., Ltd. is −3.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kim Forest Enterprise Co., Ltd. (6645)?
The operating margin of Kim Forest Enterprise Co., Ltd. is −22.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kim Forest Enterprise Co., Ltd. (6645)?
Revenue at Kim Forest Enterprise Co., Ltd. is growing +23.2% versus a year earlier (3y avg −6.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Kim Forest Enterprise Co., Ltd. (6645) generate?
The free cash flow of Kim Forest Enterprise Co., Ltd. is −114M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Kim Forest Enterprise Co., Ltd. (6645) carry?
The net debt of Kim Forest Enterprise Co., Ltd. is 262M TWD (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Kim Forest Enterprise Co., Ltd. in the live analysis

One click puts Kim Forest Enterprise Co., Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.